West Enclave Merger

The filing confirms the trust mechanics, the $10.10 per-share redemption value, and the 21-month combination period, all critical for investors tracking redemption deadlines and trust value. The conversion of 500,000 founder shares from forfeitable to non-forfeitable status upon the over-allotment exercise is a key change in share structure. The disclosure of a $10,000/month administrative fee to the Sponsor and a 3.5% business combination marketing fee to EBC provides insight into sponsor and advisor compensation.

Investors tracking WENC should anchor valuation models to the documented $10.10 per-share initial trust floor and the expanded $116,150,000 aggregate balance following the full over-allotment, which dictates the definitive baseline for per-share redemption payouts absent accrued interest. The 21-month deadline establishes a hard expiration window that necessitates monitoring for shareholder extension votes or binding merger announcements before the clock runs out. The Sponsor’s explicit liability shield protects the $10.10 threshold from third-party vendor erosion, while the 15% concert-group redemption cap informs how large block positions might navigate tender offers versus proxy votes. The May 13, 2026 separation date immediately introduces distinct liquidity in underlying shares and tradable fractional rights, reshaping secondary market behavior ahead of any target declaration. All capital structures, underwriting economics, founder dilution, and administrative obligations are sourced directly from the registrant’s audited filings and officer-signed disclosures.

Establishes the trust value, redemption terms, deadline (21 months from May 1, 2026), sponsor lock-ups, and the search mandate focused on Latin America/U.S. businesses. Investors can now track trust erosion, deal progress, and redemption deadlines.

The trust per-share value is elevated to $10.10 by structured funding, offering marginally higher redemption values but amplifying dilution consequences for remaining shareholders. The sub-penny acquisition cost of founder shares and the low-cost transfer of over one million founder shares to affiliates and directors create strong incentives for insiders to pursue a business combination quickly to avoid liquidation, where their investments would become worthless, potentially encouraging acceptance of riskier or less favorable targets.

Accelerating the effective date compresses the regulatory waiting period, positioning the SPAC closer to pricing and capital raising prior to the January 29, 2028 shareholder redemption window. The filing confirms active underwriting distribution and ongoing SEC engagement rather than passive status maintenance. No claims regarding business combinations, target companies, projected revenue, market size, operational strategy, technology, partnerships, litigation, or specific sponsor conduct beyond the stated distribution compliance are contained herein; all assertions regarding prospectus dissemination and regulatory adherence originate solely from EarlybirdCapital, Inc. and signatory Steven Levine.

Establishes the final terms and structure of the SPAC's IPO, including trust per-share amount, redemption rights, sponsor economics, dilution tables, and risk factors. Investors can now assess the SPAC's baseline terms before any deal is announced.

What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026, filed by West Enclave Merger Corp., a blank-check company incorporated in Cayman Islands, formed to effect a business combination. This is the company's first 10-Q following its IPO on April 29, 2026 and the full exercise of the over-allotment option on May 6, 2026. The filing reflects the company's initial public offering and the immediate post-IPO period. Key changes: (1) IPO of 11,500,000 units at $10.00 per unit, generating gross proceeds of $115,000,000; (2) sale of 466,250 Private Placement Units at $10.00 per unit, generating $4,662,500; (3) an EBC loan of $287,500 to ensure the trust account holds $10.10 per unit; (4) total of $116,150,000 deposited in the trust account, which as of June 30, 2026 had grown to $116,801,451 due to interest, resulting in a trust redemption value of $10.16 per share; (5) working capital of $823,944 and cash of $879,639; (6) net income of $509,855 for the quarter and $469,457 for the six-month period, mostly from interest income; (7) the company has not yet identified or announced a business combination target; (8) no changes to the redemption mechanics or deadline (21 months from IPO, i.e., until February 2028); (9) no insider trading arrangements or changes in internal controls. Why it matters: For investors tracking redemption deadlines and trust value, this filing confirms the trust value per share is $10.16, above the initial $10.10, which is favorable for public shareholders if they choose to redeem. The company is still in the search phase with no deal announced, so the redemption deadline remains February 2028. The cash burn rate ($141,596 per quarter) is manageable given the working capital. The filing also shows that the sponsor and EBC have committed to the standard lock-up and waiver agreements. There are no red flags or changes in risk factors. The materiality is low as this is a routine quarterly update with no substantive changes to the SPAC's structure or timeline.

What changed: A joint filing agreement attached to a Schedule 13G beneficial ownership report, executed by Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross. This routine compliance exhibit establishes that the three named parties will file a single Statement of Acquisition of Beneficial Ownership on behalf of all signatories pursuant to Rule 13d-1(k). It assigns shared responsibility for timely submission and individual responsibility for the completeness and accuracy of each party’s own disclosures, while disclaiming liability for the others’ data unless inaccuracies are known. The text contains no statements regarding redemption windows, trust account mechanics, extension proposals, merger negotiations, or sponsor conduct. It also contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel. Why it matters: Investors tracking the redemption calendar, trust value, January 29, 2028 deadline, or deal progress will find this filing operationally neutral. It solely formalizes coordinated regulatory disclosure by allied investment managers, reflecting standard portfolio administration rather than capital commitment, target identification, or corporate action. No new voting timelines, cash outflow events, or governance shifts are triggered by this agreement.

What changed: Quarterly report on Form 10-Q for the blank-check company West Enclave Merger Corp. for the quarter ended March 31, 2026, covering the pre-IPO formation period and disclosing IPO and over-allotment closings that occurred after quarter-end. This is the company's first 10-Q; it covers the pre-revenue, pre-IPO formation period from inception (December 9, 2025) through March 31, 2026. The material subsequent events are the IPO of 10,000,000 units at $10.00 on May 1, 2026, the full exercise of the 1,500,000-unit over-allotment on May 6, 2026, and concurrent private placements totaling 466,250 units. These actions deposited $116,150,000 ($10.10 per unit) into the trust account. The trust value per public share is $10.10. The deadline to complete a business combination is 21 months from the IPO closing (i.e., by January 29, 2028). The company confirms it has not yet commenced operations and has no revenues. Why it matters: The filing confirms the trust mechanics, the $10.10 per-share redemption value, and the 21-month combination period, all critical for investors tracking redemption deadlines and trust value. The conversion of 500,000 founder shares from forfeitable to non-forfeitable status upon the over-allotment exercise is a key change in share structure. The disclosure of a $10,000/month administrative fee to the Sponsor and a 3.5% business combination marketing fee to EBC provides insight into sponsor and advisor compensation.

What changed: Routine compliance 8-K Current Report accompanied by Exhibit 99.1 (audited balance sheet) and Exhibits 99.2 and 99.3 (press releases), serving as a factual registration update rather than a merger proxy, resignation notice, or lawsuit. This document first establishes the precise legal and financial architecture governing public shareholder redemptions and trust preservation. According to the registrant’s audited balance sheet dated May 1, 2026, $101,000,000 was deposited into a trust account, which the accompanying notes explicitly define as an initial redemption value of $10.10 per Public Share. On May 6, 2026, subsequent to the balance sheet date, the Company deposited an additional $15,150,000 derived from over-allotment proceeds, supplementary private placements, and an EBC loan draw, raising the aggregate Trust deposit to $116,150,000, as detailed in Note 10. Regarding redemption mechanics, the notes stipulate that public shareholders may elect to redeem shares for a pro rata portion of the Trust Account, initially $10.10 plus pro rata interest net of taxes payable on income earned. The combination period is contractually fixed at 21 months from the May 1, 2026 IPO closing, with the documents stating no automatic extension applies; if the period expires unextended and uncompleted, the Company will redeem 100% of public shares at a per-share price equal to the Trust deposit minus $100,000 for liquidation expenses. Sponsor conduct is bound by waiver agreements noted in the filing wherein the Sponsor and EBC relinquished redemption rights for all founder and private shares. The Sponsor additionally assumed liability to the Company if third-party claims reduce the Trust to below $10.10 per Public Share, though this obligation explicitly excludes claims by entities that executed access waivers or the Company’s independent auditors. Furthermore, the notes restrict any public shareholder acting in concert from redeeming more than 15% of public shares without prior written consent during a shareholder approval process. Beyond these structural mechanics, the press releases authored by Co-Chief Executive Officers Emilio Mahuad Quijano and Adrian Otero Rosiles state the Company’s strategic mandate targets high-quality businesses operating in Latin America or U.S. companies whose operations or growth are positioned to benefit from economic interconnection with Latin America, particularly Mexico. Capital raise specifics confirm the IPO sold 10,000,000 units at $10.00 for $100,000,000 gross proceeds, paired with a concurrent private placement of 425,000 units for $4,250,000. The May 6, 2026 over-allotment exercise sold 1,500,000 additional units for $15,000,000 and 41,250 private units for $412,500. Separately, Exhibits 99.2 and 99.3 announce that commencing May 13, 2026, holders may elect to separately trade ordinary shares under ticker “WENC” and rights under “WENC RT” through their brokers, with each right converting to one-tenth of one ordinary share upon business combination completion or expiring worthless if none occurs. Underwriting compensation is quantified in Note 6: EarlyBirdCapital, Inc. received a $0.20 per unit cash discount ($2,000,000 initially, plus $300,000 upon over-allotment closing) and is contracted to receive a marketing fee of 3.5% of gross IPO proceeds upon business combination consummation, guaranteed at a minimum of $2,000,000. Founder equity allocations recorded in Note 5 detail 3,833,333 shares purchased by the Sponsor for $25,000, 250,000 shares purchased by EBC for $1,630, and 1,380,000 shares allocated to non-managing members recognized at a fair value of $1.48 per share ($2,042,400 aggregate). The audited balance sheet reports $1,142,992 in unrestricted cash, $22,000 in prepaid expenses, $535,685 in total liabilities, and a shareholders’ equity of $629,307 reflecting a $(103,804) accumulated deficit. Why it matters: Investors tracking WENC should anchor valuation models to the documented $10.10 per-share initial trust floor and the expanded $116,150,000 aggregate balance following the full over-allotment, which dictates the definitive baseline for per-share redemption payouts absent accrued interest. The 21-month deadline establishes a hard expiration window that necessitates monitoring for shareholder extension votes or binding merger announcements before the clock runs out. The Sponsor’s explicit liability shield protects the $10.10 threshold from third-party vendor erosion, while the 15% concert-group redemption cap informs how large block positions might navigate tender offers versus proxy votes. The May 13, 2026 separation date immediately introduces distinct liquidity in underlying shares and tradable fractional rights, reshaping secondary market behavior ahead of any target declaration. All capital structures, underwriting economics, founder dilution, and administrative obligations are sourced directly from the registrant’s audited filings and officer-signed disclosures.

What changed: A Schedule 13D beneficial ownership report (filing reference 0001193125-26-220248). The supplied text contains only the filing header and a system-generated note stating 'Structured holder table not present in this XML variant.' No acquiror name, share count, percentage held, warrant position, funding source, amendment flag, or voting agreement is disclosed. Consequently, there are no alterations to the redemption timeline, trust distribution mechanics, extension proposal schedule, SPAC target search status, or sponsor governance conduct reflected in this excerpt. Why it matters: Schedule 13D submissions mark regulatory notifications of significant equity accumulation, often preceding merger negotiations, proxy solicitations, or liquidity events. Because the holding table failed to render, investors cannot assess whether new capital has entered WENC ahead of the 2028-01-29 search deadline, whether a sponsor affiliate or institutional holder is positioning shares to influence a future de-SPAC transaction, or whether accumulated stockholders plan to redeem at the currently tracked $10.16 per-share trust level. The absence of structured data means the filing does not shift the existing redemption calendar, trust valuation baseline, or extension posture. Should the underlying exhibit resolve and include representations regarding customer pipelines, revenue forecasts, market sizing, technology integration, strategic partnerships, pending litigation, or executive transitions, each assertion would require direct attribution to the named filer or affiliated management team per SEC disclosure standards.